The latest World Health Organization (WHO) classification from 2015 has grouped lung and
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …

The annual incidence of lung neuroendocrine tumour has been reported to be 1.35/100
000/year and the overall age adjusted incidence for thymic carcinoid 0.02/100 000/year. Of …

Pulmonary carcinoid tumors are neuroendocrine malignant tumors that make up 1% to 2%
of all lung tumors. According to histopathologic criteria, carcinoids can be divided into typical …

ABSTRACT Background Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity
of randomized studies, this expert consensus document represents an initiative by the …

Neuroendocrine tumors (NETs) of the lung comprise a heterogeneous population of tumors
ranging from welldifferentiated bronchial NETs to highly malignant and poorly differentiated …

Neuroendocrine neoplasms are ubiquitous tumors found throughout the body, most
commonly in the gastrointestinal tract followed by the thorax. Neuroendocrine cells occur …

Neuroendocrine tumors are a unique malignant neoplasm that can arise from the respiratory
tree. Although well‐differentiated bronchial neuroendocrine tumors (also called carcinoid …

Pulmonary neuroendocrine (NE) tumors include a spectrum of tumors from the low-grade
typical carcinoid (TC) and intermediate-grade atypical carcinoid (AC) to the high-grade large …

Neuroendocrine tumors of the lung (Lu-NETs) embrace a heterogeneous family of
neoplasms classified into four histological variants, namely typical carcinoid (TC), atypical …

Study objective Typical pulmonary carcinoid tumors are well-differentiated neuroendocrine
tumors that are associated with good patient survival rates, while atypical carcinoid tumors …